You are here

Article Text

Article menu
Download PDFPDF
Industry watch
The rise of disposable JUUL-type e-cigarette devices
  1. Rebecca Williams1,2
  1. 1 Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
  2. 2 Center for Health Promotion and Disease Prevention, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, USA
  1. Correspondence to Dr Rebecca Williams, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA; rebeccawilliams{at}unc.edu

https://doi.org/10.1136/tobaccocontrol-2019-055379

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    For the first few years of the vaping epidemic, to draw in smokers, the tobacco industry provided disposable ‘try it and throw it out’ cigalike electronic cigarettes (e-cigarettes), potentially driven by desire to convince people to try a new product that looked similar to cigarettes with a low initial cost—about the same as (or less than) a pack of cigarettes1; much less than a typical reusable e-cigarette starter kit. As vaping became more widespread and normative and users moved into larger tank and mod style e-cigarettes,2 there was less need to persuade people to try e-cigarettes with a disposable product. Moreover, their availability from online vendors became more scarce and expensive, with the proportion of online vendors selling disposable e-cigarettes dropping from 55.2% in …

    View Full Text

    Footnotes

    • Contributors RW wrote this Industry Watch paper in full and takes responsibility for the integrity and accuracy of the information presented.

    • Funding This work was funded by a grant 5R01CA169189 from the National Cancer Institute.

    • Disclaimer The National Cancer Institute had no role in the design and conduct of the study; collection, management, analysis and interpretation of the data; preparation, review or approval of the manuscript; nor decision to submit the manuscript for publication.

    • Competing interests No, there are no competing interests.

    • Patient consent for publication Not required.

    • Provenance and peer review Not commissioned; externally peer reviewed.

    • Data availability statement All data relevant to the study are included in the article.